Direxion S&P Biotech Bull 3X ETF (LABU)

[tw0122]

All in at $12.82 LABU. hilarious how they hammered this sector bio this morning. $12.80s will hold them for a while unless exceptions happen that is the plan

[farooq]

Making new low of the year also multi year low, I nimble a little bit but seems I may have to take hair cut.Sold 12.50 weekly put for 0.85 Cents and bought September calls.
Seems no support although volume is very low. Which also means buyers are not willing to sell. Let's see at end of the day buyer jumps in or not. War put many traders on side line.
Short sellers have a field day.

[Citrati]

Don't know why so dead here. A great morning already for LABU.

[naturesway]

!

[wadirum1]

Wow, this has been cut by 2/3 over past 2 months. Yes, we all already know this. But wow.

[Citrati]

Yes, I already completed 1 LABU scalp today.

Green Trades.

[tw0122]

Looking good buy when all else in fear. Buy the dips says MMRI.

Mannarino Market Risk Indicator

89.1

Low 50-100
Moderate 100-200
High 200-300
Extreme 300+

(DXY = 96.03) * (TNX = 1.493) / 1.61
12/23/21 13:44 EST

[Citrati]

Yes on that.
Patience pays now and then. Nice UVXY move twice after the opening move and very solid LABU move after its opening dip.

[tw0122]

And most importantly the lower the manipulated 10 year goes the easier time laboratory Pharma companies can bubble up.

[Citrati]

Check out how closely LABU relates to XBI recently.

[jellis]

Higher and looks higher still. I like the volatility

[value1008]

Absolutely crazy action on this one. I had been watching it since the last plunge to $62 and rebound up to mid $80s a few weeks ago and bought in on Friday at $58 avg, missed chance to sell in $65s, then had to watch it go to $50 this a.m. Sold everything in $59.90s for a small gain of $800.

"Coulda woulda shoulda..." and i would have made $5k easy in a couple of days had i sold even in $63s yesterday pre-mkt and bought in low $50s today and sold at $59.

I do think this should move higher, but there's been a lot of "bad news" algorithms plunging this down on chatter about drug price controls, the Biden admin waiving vaccine patents, and of course the big pullback on Nasdaq and tech.

I may put in some bids in low-to-mid $50s to see if more bottom-testing occurs on the XBI and LABU.

On the other hand, if Nasdaq and smallcaps show a continuing rebound tomorrow, XBI & LABU may jump right back up into the mid-to-upper $60s and higher..... We shall see.....

[blue finch]

This looks about right to go up

[LG91]

Market and Bio Tech are down but this one still up, I can see money market control this one.

[$treet $inatra]

Biotechs running today +18.25% today ~

[Traderprofessional1]

STOCK MARKET WILL CRASH , only 2 stocks will SKYROCKET $VISL $ZOM BUT these 2  stocks prices will be followed by a a Big Spike Typically prices rise quickly and significantly, growing far beyond their previous value in a short period of time. These tock haveHuge Insider Buying and Big Firms Buying

[Traderprofessional1]

INVVY will Dip and all to $3.00 by end of day unfortunately, the NEXT BIG RUNNER Will Be TNNP)

[Traderprofessional1]

#STOCKS #StockMarket #biotech #LABU #StockMarketCrash20 #STOCKSTOBUY #stockmarkets #STOCKCRASH Unfortunately ?? The STOCKS will Crash, the Markets will get Totally Blood Red ,SELL THIS IS UR FINAL WARNING OR LOSE ALL UR $$$$ ?? MONEY!!! Only 1 ETF u will make $$ is on #LABD

[Traderprofessional1]

Buy LABD its going UP from $5.60 to $25.00 BIOS WILL CRASH HARD, with the Market But LABD will 3x In Value=$$$$

[Traderprofessional1]

biotechnology will sink hard and fast this morning ?? my brokers advised me to Sell ASAP and Buy Labd & Tilray they will go up 500%

[Traderprofessional1]

LABU Gonna Tank markets, All Bios going to Tank Hard, SELL LABU buy TILRAY its going up from $7.55 to $15.00 =$$$

[Traderprofessional1]

$LABD #LABD is the only Stock ETF fund where you can DOUBLE EVEN possibly triple your money here, Market will Tank and crash hard, Biotech will Sink , No cure, no vaccine for the Caronavirus!!! Not good BUY LABD =$$$$$$$

[blindjohn]

Starter

[tw0122]

Alicia Levine believes Wall Street is making a big mistake.

The chief strategist at BNY Mellon contends it’s still not accurately pricing in the growing possibility that U.S.-China trade talks will ultimately fail.


“The market got the wake-up call on May 5, and it hit the snooze button — expecting this to go away with a tweet,” she said Thursday on CNBC’s “Futures Now. ”

Levine is alluding to President Donald Trump’s series of tweets on May 5 that threatened new tariffs.

Since then, stocks have been on a roller-coaster ride. The S&P 500 is down 4% and the Dow has fallen around 3.5%. The tech-heavy Nasdaq is off more than 6%.


“I think it gets worse before it gets better,” she said. “The trade war is turning into a tech war, and this could go on longer. It could be deeper, and it could be harder to come up with a resolution.”

To help insulate investment portfolios against the trade war fallout, Levine recommends going to an unloved portion of the market: health care.


“It was a dog. Nobody wanted to own health care, and the Democrats have been beating up on the health-care area because they want to introduce socialized medicine and single-payer,” she said. “These multiples have gotten crushed.”

Levine predicts the more popular defensive plays in this environment may soon face trouble.

“I’m worried about utilities and real estate just because they are the obvious trade, and I believe they’re overpriced, ” Levine said.

[tw0122]

Goood Buy here with the Mafia Of Drug Cartels fixing prices and raising them as they please investing in LABU is a no brainer. Monopoly in upwards pricing rules.

Nearly every state in the US is part of a lawsuit against leading pharmaceutical companies which colluded to raise prices on generic medications by as much as 1,000 percent.

Boom Bust talks to Mollye Barrows of America’s Lawyer about the case with the big pharma companies which some are referring to as “the largest cartel case in the history of the United States.”

She says executives of 20 companies met with each other to fix prices and divide the market share of profits for more than 100 generic drugs.

[stockguard]

Now until the end of July should be great for biotech/healthcare even in an overall market correction. Keep an an eye out on the charts for another add or entry, GL, We`ll ment ment so money. (-;

[Bourbon_on_my_cornflakes]

Wild ride today, but made a profit

Trading bought at $47, sold at $48.12, then watched the end of day plunge.

Just getting started with this beast, sure are plenty of opportunities to make $$ but sure have to be fast.

[stockguard]

Filled gap yesterday now back on track to head higher.

[blindjohn]

Topped out today for a while. Couple weeks in labd from here

[No-Quarter]

Bio season? Color me intrigued. Do you see this returning in 2019?

[No-Quarter]

Where do you think this is headed in January?

[blindjohn]

Commenced!

[blindjohn]

Laboob big week long bounce coming

[stockguard]

Oversold ready for the gap fill and any more this wants to give! RSI turning up today too......

[TREND1]

LABU RSI 5

[Mr_Doug]

Anyone buying for a day trade or swing? Debating whether it's chasing at this point with the flat market.

[Swampdude]

OK, so we are in an abstract order, kool.

Pluto!

[blindjohn]

Mars

[Swampdude]

Neptune?

[blindjohn]

Uranus

[blindjohn]

Labu Chart https://twitter.com/silvertonstock/status/815082009357729792

Hope to see this slowly consolidate down in the channel until the gap or gaps fill before February, when "bio season" commenced last year. Labu $25-$27 could be the buy zone & I have a feeling it could rip to $50-$60 in a month or two after that as long as the overall market remains bullish. I think bios ripping will only add fuel to the overall market's bull power when it finally does join the party.

[value1008]

These days i often aim for setting an auto-sell at a higher price rather than putting in stop-loss points. These 3x etfs swing so wildly that there is a good chance to "sell high" rather than get stop-loss-sold low.

Of course, if you're already well into the green and not sure how much higher the etf can reasonably run, a trailing stop makes good sense.

Me, i like to look at the charts, especially plugging in, not just the 50dma, 125dma, and 200dma, but also things like the 9dma and 26dma (which will show at Stockcharts.com when you plug in the Ichimoku cloud indicator)... and i find that the HFT algos used by the big hedgies are often swinging the etfs and their 3x etfs between these support and resistance lines.

This gives me info for where to put those auto-sell points with a high probability of getting profits up to those points.

[ASPD_Capital]

Trailing stop got me out in the morning jump. Thinking I'll take that and wait for the Fed meeting to set some new or continuing trends.

[value1008]

I thought that news last night of that Senate-passed Cures Act would have zoomed the sector up this a.m. but evidently the expected passing of the legislation was already "baked in," given the almost unanimous support for the bill, hence the lack of a big positive upmove.

Well, at least LABU closed in the green and it looks like it could again challenge resistance up at its 50dma within the next few days, and maybe leap above it again.

[ASPD_Capital]

Saw the Times mention on Trump's thought about drug prices the same time as the Research Bill...definitely weird action.

[king oil]

the market is breaking record highs and pharma just keeps tanking further and further. unreal.

[ASPD_Capital]

Bill passed, up for Obama's approval tomorrow. Could be good for a quick news flip on LABU.

[king oil]

They're about to fast track a new bill that makes it easier to develop new drugs. Big pharma lobbied hard for it. Not sure why these stocks keep dropping.

[dabonenose]

King,,,well it's a 3x so very, very, volatile.

I sold at 47, and I'm waiting till the sharks are done swimming the shallows before I stick my toe back in the water,,,lol.

[king oil]

This stock can't seem to hold any gains.